- Home
- ZDAI vs EDSA Comparison
ZDAI vs EDSA Comparison
Compare ZDAI & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZDAI
- EDSA
- Stock Information
- Founded
- ZDAI 2022
- EDSA 2015
- Country
- ZDAI Hong Kong
- EDSA Canada
- Employees
- ZDAI N/A
- EDSA N/A
- Industry
- ZDAI General Bldg Contractors - Nonresidential Bldgs
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- ZDAI Consumer Discretionary
- EDSA Health Care
- Exchange
- ZDAI Nasdaq
- EDSA Nasdaq
- Market Cap
- ZDAI 13.5M
- EDSA 15.4M
- IPO Year
- ZDAI 2024
- EDSA N/A
- Fundamental
- Price
- ZDAI $0.53
- EDSA $2.24
- Analyst Decision
- ZDAI
- EDSA Strong Buy
- Analyst Count
- ZDAI 0
- EDSA 2
- Target Price
- ZDAI N/A
- EDSA $13.00
- AVG Volume (30 Days)
- ZDAI 69.7K
- EDSA 21.9K
- Earning Date
- ZDAI 08-29-2025
- EDSA 08-08-2025
- Dividend Yield
- ZDAI N/A
- EDSA N/A
- EPS Growth
- ZDAI N/A
- EDSA N/A
- EPS
- ZDAI N/A
- EDSA N/A
- Revenue
- ZDAI $19,275,673.00
- EDSA N/A
- Revenue This Year
- ZDAI N/A
- EDSA N/A
- Revenue Next Year
- ZDAI N/A
- EDSA N/A
- P/E Ratio
- ZDAI N/A
- EDSA N/A
- Revenue Growth
- ZDAI 56.11
- EDSA N/A
- 52 Week Low
- ZDAI $0.37
- EDSA $1.55
- 52 Week High
- ZDAI $107.36
- EDSA $5.00
- Technical
- Relative Strength Index (RSI)
- ZDAI N/A
- EDSA 52.38
- Support Level
- ZDAI N/A
- EDSA $2.02
- Resistance Level
- ZDAI N/A
- EDSA $2.28
- Average True Range (ATR)
- ZDAI 0.00
- EDSA 0.13
- MACD
- ZDAI 0.00
- EDSA -0.01
- Stochastic Oscillator
- ZDAI 0.00
- EDSA 59.72
About ZDAI Primega Group Holdings Limited Ordinary Shares
Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.